Greg Hunt proposes changes to reporting scheme to help address medicine shortages The Federal Health Minister wants to make the reporting scheme mandatory rather than voluntary, with legal definitions of medicine shortage and penalties for non-compliance.
Unfounded claims about complementary medicine put patients in danger: RACGP Proposed legislation to legalise un-scientific claims on complementary medicines will place Australian patients at risk and must not come into force, Chair of the RACGP Expert Committee – Quality Care Dr Evan Ackermann told newsGP.
Transvaginal mesh implants inquiry: What GPs need to know Dr Magdalena Simonis – GP and RACGP representative on the recent Senate inquiry into transvaginal mesh implants – writes for newsGP about the outcomes of the inquiry, and what they mean for GPs and their patients.
Unfounded and unscientific claims have no place in legitimate healthcare RACGP President Dr Bastian Seidel expresses his dismay at news of the approval of the Therapeutic Goods Administration’s list of ‘permitted indications’.
Alarming health claims must not appear on complementary medicine: RACGP President Many of the items included on the Therapeutic Goods Administration’s list of ‘permitted indications’ make unfounded and unscientific claims that could lead to patient harms, RACGP President Dr Bastian Seidel writes for newsGP.
RACGP codeine resources now available The RACGP has created a range of clinical and professional resources – including an online information repository, prescribing guidelines and a 12-point opioid challenge – designed to help GPs throughout Australia address issues relating to the up-scheduling of over-the-counter codeine products.
New RACGP codeine resource now available The RACGP has created a new online repository to assist GPs in addressing issues relating to the 1 February up-scheduling of codeine.
RACGP flags reservations regarding TGA amendment bills The RACGP is concerned that a Therapeutic Goods Administration list of permitted indications includes numerous ‘traditional’ indications that encourage the pharmaceutical industry to evade products’ scientific proof of efficacy, endorse pseudoscience, and will mislead and confuse consumers.
Codeine up-scheduling may offer chances for patient education and holistic care Next year’s planned up-scheduling of over-the-counter codeine products may offer GPs a direct opportunity to provide patients with more holistic care to help address possible issues of addiction and misuse.
Side effects from transvaginal mesh: How GPs can help The Therapeutic Goods Administration (TGA) recently banned the use of transvaginal mesh products for the treatment of pelvic organ prolapse.